- IN₹2.16bn
- IN₹1.91bn
- IN₹1.68bn
- 87
- 43
- 51
- 69
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.67 | ||
Price to Tang. Book | 2.67 | ||
Price to Free Cashflow | 20.09 | ||
Price to Sales | 1.29 | ||
EV to EBITDA | 9.23 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 16.52% | ||
Return on Equity | 13.83% | ||
Operating Margin | 8.15% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 1,361.46 | 1,093.17 | 1,365.57 | 1,608.49 | 1,678.22 | n/a | n/a | 6.22% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -25.8 | -46.27 | +175.63 | +25.84 | +42.03 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Denis Chem Lab Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing pharmaceutical transfusion solution in bottles. It offers a range of sterile intravenous injectables for human and veterinary consumption. Its product offerings include carbohydrate solutions, carbohydrate in sodium chloride solutions, sodium chloride solutions, potassium chloride solutions, sodium lactate/ Ringer's solution, multi electrolyte solutions, dialysis solutions, mannitol solutions, irrigation solutions, plasma volume expanders, amino acids, antibiotic solutions and other miscellaneous products. It manufactures sterile intravenous injectables in filled volumes ranging from 100 milliliters to 10 liters. In addition to manufacturing its own products, it sells under its own brands. The Company also uses its facility to manufacture products on a contract basis for third parties, including certain multinational pharmaceutical companies.
Directors
- Dinesh Patel NEC (87)
- Nirmal Patel CEO
- Vikram Joshi CFO
- Anal Desai CCO
- Himanshu Patel MDR
- Anar Patel NED
- Gaurang Dalal NID (63)
- Hemendrakumar Shah NID (69)
- Gauri Trivedi NID (61)
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- July 15th, 1980
- Public Since
- February 21st, 2014
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 13,876,668
- Address
- Bl 457, Village Chhatral, AHMEDABAD, 380015
- Web
- https://denischemlab.com/
- Phone
- +91 7926925716
- Auditors
- M/s. Shah & Shah
Upcoming Events for 537536
Q3 2025 Denis Chem Lab Ltd Earnings Release
Similar to 537536
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
As of Today at 20:13 UTC, shares in Denis Chem Lab are trading at IN₹154.55. This share price information is delayed by 15 minutes.
Shares in Denis Chem Lab last closed at IN₹154.55 and the price had moved by +43.17% over the past 365 days. In terms of relative price strength the Denis Chem Lab share price has outperformed the S&P BSE 100 Index by +4.93% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Denis Chem Lab dividend yield is 1.62% based on the trailing twelve month period.
Last year, Denis Chem Lab paid a total dividend of IN₹2.50, and it currently has a trailing dividend yield of 1.62%. We do not have any data on when Denis Chem Lab is to next pay dividends.
We do not have data on when Denis Chem Lab is to next pay dividends. The historic dividend yield on Denis Chem Lab shares is currently 1.62%.
To buy shares in Denis Chem Lab you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹154.55, shares in Denis Chem Lab had a market capitalisation of IN₹2.16bn.
Here are the trading details for Denis Chem Lab:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 537536
Based on an overall assessment of its quality, value and momentum Denis Chem Lab is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Denis Chem Lab. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -13.34%.
As of the last closing price of IN₹154.55, shares in Denis Chem Lab were trading -3.37% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Denis Chem Lab PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹154.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Denis Chem Lab's management team is headed by:
- Dinesh Patel - NEC
- Nirmal Patel - CEO
- Vikram Joshi - CFO
- Anal Desai - CCO
- Himanshu Patel - MDR
- Anar Patel - NED
- Gaurang Dalal - NID
- Hemendrakumar Shah - NID
- Gauri Trivedi - NID